112
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Effects of cyclosporin A administration on gene expression in rat brain

, PhD, , , &
Pages 614-623 | Received 24 Jun 2010, Accepted 08 Mar 2011, Published online: 04 May 2011
 

Abstract

Primary objective: The immunosuppressant cyclosporin A (CsA) is reported to have a strong anti-ischemic effect. Although this neuroprotective effect is speculated to be related to the blockade of a mitochondrial permeability transition pore (mPTP), the underlying molecular mechanism remains to be elucidated. This study focused on the effect of CsA on transcriptional regulation in brain cells.

Methods: CsA and a control substance were injected into rat brains and purified extracted mRNA. Both mRNAs were compared using a cDNA subtraction technique.

Results: Nine significantly up-regulated genes and seven significantly down-regulated genes were detected following CsA administration. All of the up-regulated genes are neurotrophic or reported to have roles in regeneration of brain tissue. Among the down-regulated genes, three are known to be detrimental to neuronal cells and are also reported to facilitate the pathology of Alzheimer's disease (AD) and four genes are related to oxidative metabolism.

Conclusions: Strong immunosuppression would present as a side-effect during CsA use as a neuroprotectant. The results of this study will help to discriminate between the CsA immunosuppressive effect and the neuroprotective effect at the molecular level and may lead to the development of new conceptual and pharmacological tools.

Abbreviations
CsA=

cyclosporin A

mPTP=

mitochondrial permeability transition pore

AD=

Alzheimer's disease

BAD=

Bcl-associated death protein

CyPD=

cyclophilin D

NFAT=

Nuclear factor of activated T-cells

SSH=

suppression subtractive hybridization

EF-1=

Elongation factor-1

SCD2=

Stearoyl-CoA desaturase 2

TCP1=

T-complex protein 1

CCT=

Chaperonin-containing TCP1

Fez1=

fasciculation and elongation protein zeta 1

PKC=

protein kinase C

TBP=

TATA binding protein

TAF=

TBP-associated factor

SPT=

suppressor of yeast transposable elements

GCN=

general control non-derepressible

GPR=

G-protein-coupled receptor

dbEST=

Database of Expressed Sequence Tags

CNS=

central nervous system

HA=

head activator

ZWINT=

ZW10 interactor

rab=

ras-related in brain

SNAP25=

synaptosomal-associated protein 25

CCP=

classical complement pathway

ER=

endoplasmic reticulum

COP1=

coat protein 1

MDH=

Malate dehydrogenase

OXR1=

oxidation resistance 1

AK3=

Adenylate kinase 3

HIF1=

hypoxia-inducible factor-1

PAS=

Per/Arnt/Sim

PGK-1=

Phosphoglycerate kinase 1

VILIP=

Visinin-like Ca2 + binding protein.

Abbreviations
CsA=

cyclosporin A

mPTP=

mitochondrial permeability transition pore

AD=

Alzheimer's disease

BAD=

Bcl-associated death protein

CyPD=

cyclophilin D

NFAT=

Nuclear factor of activated T-cells

SSH=

suppression subtractive hybridization

EF-1=

Elongation factor-1

SCD2=

Stearoyl-CoA desaturase 2

TCP1=

T-complex protein 1

CCT=

Chaperonin-containing TCP1

Fez1=

fasciculation and elongation protein zeta 1

PKC=

protein kinase C

TBP=

TATA binding protein

TAF=

TBP-associated factor

SPT=

suppressor of yeast transposable elements

GCN=

general control non-derepressible

GPR=

G-protein-coupled receptor

dbEST=

Database of Expressed Sequence Tags

CNS=

central nervous system

HA=

head activator

ZWINT=

ZW10 interactor

rab=

ras-related in brain

SNAP25=

synaptosomal-associated protein 25

CCP=

classical complement pathway

ER=

endoplasmic reticulum

COP1=

coat protein 1

MDH=

Malate dehydrogenase

OXR1=

oxidation resistance 1

AK3=

Adenylate kinase 3

HIF1=

hypoxia-inducible factor-1

PAS=

Per/Arnt/Sim

PGK-1=

Phosphoglycerate kinase 1

VILIP=

Visinin-like Ca2 + binding protein.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.